BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
Contraline
/
Kevin Eisenfrats
KE
Kevin Eisenfrats
Co-Founder and CEO
Contraline
Therapeutic Areas
Reproductive Health
Contraception
Contraline Pipeline
Drug
Indication
Phase
NES/T
Male Contraception
Phase 3
ADAM
Male Contraception
Pre-clinical
Leadership Team at Contraline
JT
James Tursi, MD
Chief Scientific Officer
JM
Justin Mattice
Chief Commercial Officer
YT
Yelena Tropsha, PhD
Chief Technology Officer
AP
Alex Pastuszak, MD PhD
Chief Medical Officer
View full Contraline profile